Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nowak

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
In Vivo (Athens, Greece)|July 2, 2013
Targeting cancer with a bi-functional peptide: in vitro and in vivo resultsKaroline Meschenmoser, Young Kim, Sebastian Franken, et al.
Infectious Diseases and Therapy|January 30, 2021
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical TrialsPedro L Gonzalez, Urania Rappo, Veronica Mas Casullo, et al.
Infection and Immunity|December 20, 2012
Role of the NK cell-activating receptor CRACC in periodontitisBenjamin Krämer, Moritz Kebschull, Michael Nowak, et al.
Anticancer Research|March 8, 2011
Influencing the Wnt signaling pathway in multiple myelomaYoung Kim, Guido Reifenberger, Desheng Lu, et al.
Immunity|September 18, 2012
Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine productionLydia Lynch, Michael Nowak, Bindu Varghese, et al.
Cancer Research|April 2, 2017
<i>ATM</i> Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung AdenocarcinomaAnna Schmitt, Gero Knittel, Daniela Welcker, et al.
Kidney International Reports|November 17, 2017
Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical OutcomeKnut Michael Nowak, Oliver Witzke, Georgios C Sotiropoulos, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitisGuido Beldi, Yan Wu, Yara Banz, et al.
Jac-Antimicrobial Resistance|January 1, 2024
Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testingAmmara Mushtaq, Bremy Alburquerque, Marilyn Chung, et al.
Journal of Intensive Care|July 9, 2026
Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU casesSebastian Zeiner, Julian Rettenbacher, Nikolaus Michael Nowak, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
In Vivo (Athens, Greece)|July 2, 2013
Targeting cancer with a bi-functional peptide: in vitro and in vivo resultsKaroline Meschenmoser, Young Kim, Sebastian Franken, et al.
Infectious Diseases and Therapy|January 30, 2021
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical TrialsPedro L Gonzalez, Urania Rappo, Veronica Mas Casullo, et al.
Infection and Immunity|December 20, 2012
Role of the NK cell-activating receptor CRACC in periodontitisBenjamin Krämer, Moritz Kebschull, Michael Nowak, et al.
Anticancer Research|March 8, 2011
Influencing the Wnt signaling pathway in multiple myelomaYoung Kim, Guido Reifenberger, Desheng Lu, et al.
Immunity|September 18, 2012
Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine productionLydia Lynch, Michael Nowak, Bindu Varghese, et al.
Cancer Research|April 2, 2017
<i>ATM</i> Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung AdenocarcinomaAnna Schmitt, Gero Knittel, Daniela Welcker, et al.
Kidney International Reports|November 17, 2017
Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical OutcomeKnut Michael Nowak, Oliver Witzke, Georgios C Sotiropoulos, et al.
Hepatology (Baltimore, Md.)|August 30, 2008
Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitisGuido Beldi, Yan Wu, Yara Banz, et al.
Jac-Antimicrobial Resistance|January 1, 2024
Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testingAmmara Mushtaq, Bremy Alburquerque, Marilyn Chung, et al.
Journal of Intensive Care|July 9, 2026
Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU casesSebastian Zeiner, Julian Rettenbacher, Nikolaus Michael Nowak, et al.
Pageof 6